Lixte Biotechnology Holdings, Inc. (LIXT)
LIXT moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How LIXT actually reacts to news — the realized, point-in-time move the market made, measured across 239 labeled events over the last three years with zero look-ahead.
LIXT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 39% | 177 |
| 30-min | 0.00% | 48% | 205 |
| 60-min | 0.00% | 45% | 213 |
| to close | 0.00% | 49% | 222 |
| Middle 50% of LIXT reactions | -2.17% to +2.73% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 239 |
Half of all Lixte Biotechnology Holdings, Inc. news events land between -2.17% and +2.73% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when LIXT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to LIXT's baseline. Nothing else.
Recent LIXT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q NOMAD POWER SOLUTIONS, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K NOMAD POWER SOLUTIONS, For: Jul 31 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form DEF 14A NOMAD POWER SOLUTIONS, For: Jul 27 | SEC filing · Form DEF | SEC EDGAR | — | — | |
| Form PRE 14A NOMAD POWER SOLUTIONS, For: Jul 17 | SEC filing · Form PRE | SEC EDGAR | — | — | |
| Form 8-K NOMAD POWER SOLUTIONS, For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| LIXTE Completes Corporate Name Change to NOMAD Power Solutions, Inc.; To Begin Trading Under New Nasdaq Symbol NMAD | Press release | GlobeNewswire | — | — | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS | Press release | GlobeNewswire | -2.52% | -9.31% | |
| LIXTE Joins Russell Microcap Index | Press release | GlobeNewswire | +0.00% | +7.80% | |
| A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch | Press release | GlobeNewswire | +2.11% | +6.29% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | -0.13% | -1.32% | |
| LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026 | Press release | GlobeNewswire | +0.70% | +7.33% | |
| The AI Boom’s Real Bottleneck Is Power — and One Nasdaq Company Is Reinventing Itself to Solve It | Press release | GlobeNewswire | +0.70% | +7.33% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.87% | |
| LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS) | Press release | GlobeNewswire | -6.19% | -12.94% | |
| The New Bottleneck Isn’t Computing Power — It’s Just Power | Press release | GlobeNewswire | -0.16% | -3.58% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | -1.17% | +2.49% | |
| LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth | Press release | GlobeNewswire | -5.65% | -4.01% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: May 29 | SEC filing · Form 8-K | SEC EDGAR | -10.08% | +11.78% | |
| LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors | Press release | GlobeNewswire | -10.08% | +11.78% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.94% | -5.15% | |
| LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update | Press release | GlobeNewswire | +2.94% | -5.15% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Apr 15 | SEC filing · Form 8-K | SEC EDGAR | — | -2.97% | |
| Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference | Press release | GlobeNewswire | +0.00% | -1.01% | |
| Form 10-K LIXTE BIOTECHNOLOGY HOLD For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.97% | +0.99% | |
| LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year | Press release | GlobeNewswire | +1.45% | -1.45% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | +4.09% | -1.11% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Mar 06 | SEC filing · Form 8-K | SEC EDGAR | — | +19.23% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | -2.28% | -0.33% | |
| LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary | Press release | GlobeNewswire | -2.28% | -0.33% | |
| DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE | Press release | GlobeNewswire | — | +2.93% | |
| LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 | Press release | GlobeNewswire | +0.92% | -6.46% | |
| IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. | Press release | GlobeNewswire | +0.87% | -2.91% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.54% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | +0.06% | -0.49% | |
| LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial | Press release | GlobeNewswire | +0.00% | +1.24% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Dec 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.24% | |
| Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering | Press release | GlobeNewswire | +0.00% | +1.24% | |
| Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules | Press release | GlobeNewswire | +3.71% | +12.00% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Dec 08 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities | Press release | ACCESS Newswire | +0.24% | +6.11% | |
| LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology | Press release | ACCESS Newswire | — | +1.94% | |
| LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers | Press release | ACCESS Newswire | -0.99% | +3.70% | |
| Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Nov 25 | SEC filing · Form 8-K | SEC EDGAR | -5.42% | +2.93% | |
| LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment | Press release | GlobeNewswire | -13.32% | -13.53% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.48% | — | |
| LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3 | Press release | GlobeNewswire | +0.00% | +1.64% | |
| Form DEFA14A LIXTE BIOTECHNOLOGY HOLD | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +1.64% | |
| Form DEF 14A LIXTE BIOTECHNOLOGY HOLD For: Oct 27 | SEC filing · Form DEF | SEC EDGAR | — | -1.19% | |
| Form PRE 14A LIXTE BIOTECHNOLOGY HOLD For: Oct 16 | SEC filing · Form PRE | SEC EDGAR | -3.35% | +0.45% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the LIXT section they belong to.
Where else LIXT is measured.
LIXT earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Resverlogix Corp (RVX_TSE) | 240 | 0.00% | 32% |
| Artelo Biosciences, Inc. (ARTL) | 239 | 0.00% | 41% |
| MeiraGTx Holdings plc - Ordinary Shares (MGTX) | 239 | -0.10% | 46% |
| Ovid Therapeutics Inc. (OVID) | 239 | -0.32% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Lixte Biotechnology Holdings, Inc.'s median reaction calculated?
Every labeled LIXT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 239 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of LIXT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does LIXT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.